Page-2 of SARS-Cov-2 virus

WHO: SARS-CoV-2 variant B.1.1.529 a ‘Variant of Concern’

The World Health Organisation (WHO) designated SARS-CoV-2 variant B.1.1529 as a ‘variant of concern’. Key Points This variant of SARS-CoV-2 has been named as Omicron. This variant was first detected in Botswana region of South Africa on November 24. South Africa ..

Month: 

Study: White-tailed deer being infected with SARS-CoV-2

A new study from US shows that white-tailed deer are being infected with SARS-CoV-2, the virus causing COVID-19 in humans. Key Points During the study, Antibodies were found in 40% of deer. They were tested in between January to March 2021 across Michigan, Illinois, ..

Month: 

Covaxin approved for emergency use in 2–18-year-olds

The Subject Expert Committee on Covid-19 has approved the “emergency use” of Bharat Biotech’s Covaxin vaccine for children aged between 2-18 years old. Key Points Phase-2 and Phase-3 trials of the Covaxin vaccine by Hyderabad-based Bharat Biotech on children below ..

Month: 

EU approves Pfizer-BioNTech COVID vaccine booster

European Medicines Agency (EMA) approved the booster doses of Pfizer/BioNTech Covid-19 vaccine for people aged 18 and above on October 4, 2021. Key Facts This approval given as data for the vaccine showed a rise in antibody levels when a ..

Month: 

WHO Chief Scientist: Covid vaccination is not absolute protection

Chief scientist of World Health Organisation (WHO), Dr. Soumya Swaminathan, noted that though Covid-19 vaccines may not provide absolute protection against emerging variants of the coronavirus. However, it can reduce risks of death and complications. Highlights Dr Swaminathan further emphasised ..

Month: 

IISc-Mynvax’s heat-tolerant Covid vaccine

Indian Institute of Science (IISc) Bengaluru has developed a heat-tolerant COVID-19 vaccine formulation. While studying on animals, it was found to be effective against all current SARS-CoV-2 variants of concern. Key Points Research was published in ACS Infectious Diseases journal. ..

Month: